May Media Miscellany, for the last time: 5.31.05

Do as I say, not as I do: CNBC chairman Pamela Thomas-Graham is the newest member of the board of Idenix Pharmaceuticals, and received 15,000 stock options as a result — despite a strict company policy precluding all CNBC employees (and their spouses) from owning individual stocks. “How can CNBC cover the drug industry when she’s a director at a drug company?” says an insider in Page Six (by simply declaring bias, which apparently special people at CNBC can get away with).